Semaglutide appears to safeguard the heart even when patients lose little weight. In a massive international trial, heart attack and stroke risk dropped by 20% regardless of BMI. The benefit seems tied not just to slimming down but to deeper biological effects on inflammation, blood pressure, and vessel health. Researchers say this could expand who qualifies for the drug.
source https://www.sciencedaily.com/releases/2025/10/251030075125.htm
Committed skeptic finds himself warming to new Amazon AI products that
actually don't suck
-
If you live long enough, you'll wake up one day and find that you're living
in a world you no longer understand. Lately there are things happening with
AI ...
6 hours ago
No comments:
Post a Comment